Catalent price target lowered to $45 from $50 at Barclays

Barclays analyst Luke Sergot lowered the firm’s price target on Catalent to $45 from $50 and keeps an Equal Weight rating on the shares following the company’s preliminary Q1 results. The firm says solid spend management and better operating leverage are expected to drive significant margin expansion in the second half of the fiscal year.